Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Net Income: 2011-2025

Historic Net Income for Mimedx Group (MDXG) over the last 15 years, with Sep 2025 value amounting to $16.7 million.

  • Mimedx Group's Net Income rose 7617.97% to $16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.8 million, marking a year-over-year increase of 1464.25%. This contributed to the annual value of $421,000 for FY2024, which is 104.57% up from last year.
  • Mimedx Group's Net Income amounted to $16.7 million in Q3 2025, which was up 74.13% from $9.6 million recorded in Q2 2025.
  • In the past 5 years, Mimedx Group's Net Income ranged from a high of $16.7 million in Q3 2025 and a low of -$10.9 million during Q2 2022.
  • Moreover, its 3-year median value for Net Income was $217,000 (2024), whereas its average is $2.9 million.
  • Per our database at Business Quant, Mimedx Group's Net Income plummeted by 510.91% in 2022 and then surged by 240,350.00% in 2025.
  • Quarterly analysis of 5 years shows Mimedx Group's Net Income stood at $199,000 in 2021, then spiked by 4,839.70% to $9.8 million in 2022, then slumped by 77.73% to $2.2 million in 2023, then surged by 239.79% to $7.4 million in 2024, then surged by 7,617.97% to $16.7 million in 2025.
  • Its Net Income stands at $16.7 million for Q3 2025, versus $9.6 million for Q2 2025 and $7.0 million for Q1 2025.